Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: Wright Reports
|
$115.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
NAGAILEBEN Co Ltd Amends Consolidated Full-year Outlook for FY Ending August 2012
NAGAILEBEN Co Ltd announced that it has raised its consolidated full-year outlook for revenue from JPY 14,800 million to JPY 15,100 million, operating profit from JPY 4,379 million to JPY 4,586 million, ordinary profit from JPY 4,425 million to JPY 4,748 million, but lowered its consolidated full-year outlook for net profit from JPY 2,606 million to JPY 2,430 million and earning per share from JPY 75.68 to JPY 70.54 for the fiscal year ending August 31, 2012. This is due to the recording of JPY 555 million impairment loss on fixed assets as extraordinary loss. According to I/B/E/S Estimates, analysts on average are expecting the Company to report full-year revenue of JPY 15.30 billion and net profit of JPY 2.75 billion.
Latest Key Developments in Medical
- Share this
- Link this
- Digg this


Follow Reuters